Grace Therapeutics, Short Term Investments Over Time
| GRCE Stock | 3.58 0.32 8.21% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Grace Therapeutics, Performance and Grace Therapeutics, Correlation. Grace |
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Grace Therapeutics,. If investors know Grace will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Grace Therapeutics, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Grace Therapeutics, is measured differently than its book value, which is the value of Grace that is recorded on the company's balance sheet. Investors also form their own opinion of Grace Therapeutics,'s value that differs from its market value or its book value, called intrinsic value, which is Grace Therapeutics,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Grace Therapeutics,'s market value can be influenced by many factors that don't directly affect Grace Therapeutics,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Grace Therapeutics,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Grace Therapeutics, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Grace Therapeutics,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Short Term Investments Analysis
Compare Grace Therapeutics, and related stocks such as Viking Therapeutics, Vanda Pharmaceuticals, and Verrica Pharmaceuticals Short Term Investments Over Time
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VKTX | 13.3 M | 13.3 M | 13.3 M | 13.3 M | 13.3 M | 13.3 M | 10.1 M | 11.6 M | 276.7 M | 267.3 M | 219.3 M | 175.7 M | 118.9 M | 306.6 M | 171 M |
| VNDA | 10.1 M | 61 M | 31.6 M | 65.6 M | 68.9 M | 92.3 M | 100.9 M | 109.8 M | 196.4 M | 267.1 M | 306.7 M | 380.7 M | 331.8 M | 252.4 M | 151.7 M |
| VRCA | 79.5 M | 79.5 M | 79.5 M | 79.5 M | 79.5 M | 79.5 M | 79.5 M | 79.5 M | 79.5 M | 52.8 M | 54.8 M | 54.6 M | 0.0 | 0.0 | 0.0 |
| VRDN | 29.9 M | 29.9 M | 29.9 M | 29.9 M | 29.9 M | 29.9 M | 29.9 M | 29.9 M | 29.9 M | 2 M | 81.7 M | 154.7 M | 269 M | 374.5 M | 393.3 M |
| VRNA | 2.5 M | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 66 M | 57 M | 10.3 M | 10.3 M | 10.3 M | 10.3 M | 11.8 M | 20.1 M |
| VRTX | 66.5 M | 493.6 M | 831.8 M | 895.8 M | 761.8 M | 327.7 M | 250.6 M | 423.3 M | 518.1 M | 699 M | 670.7 M | 729.9 M | 274.5 M | 849.2 M | 579.6 M |
| VSTM | 26.9 M | 26.9 M | 46.5 M | 82.4 M | 58.8 M | 85.4 M | 48.5 M | 4.5 M | 119.8 M | 32 M | 73.4 M | 79 M | 13 M | 59.2 M | 61.7 M |
| VTGN | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Grace Therapeutics, and related stocks such as Viking Therapeutics, Vanda Pharmaceuticals, and Verrica Pharmaceuticals Short Term Investments description
Short Term Investments is an item under the current assets section of Grace Therapeutics, balance sheet. It contains any investments Grace Therapeutics, undertook that will expire in less than one year. These accounts contain financial instruments such as stocks or bonds that Grace Therapeutics, can easily liquidate in the marketplace.My Equities
My Current Equities and Potential Positions
| Grace Therapeutics, | GRCE |
Specialization | Healthcare, Biotechnology |
| Location | Quebec; Canada |
| Exchange | NASDAQ Exchange |
null 3.58
Check out Grace Therapeutics, Performance and Grace Therapeutics, Correlation. For information on how to trade Grace Stock refer to our How to Trade Grace Stock guide.You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Grace Therapeutics, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.